semaglutide for normal bmi results week by week: timeline from first dose to full results Semaglutide and BMI Explained |

Future studies should conduct patient-data-based or refined network meta-analyses of different GLP-1 RAs, doses, and MASLD populations with or without T2DM to distinguish their efficacy and safety

Those with pancreatitis or severe gastrointestinal diseases should consult their provider for alternative therapies

In many cases, yes but any switch should be done under medical supervision to ensure proper dosing and safety

While results vary, most patients will lose an average of 15% of their current body weight after 1 year

This is challenging when appetite is suppressed, which is why protein shakes formulated for GLP-1 users become valuable tools